KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Teladoc Health (TDOC) Depreciation & Amortization (IS) (2016 - 2023)

Teladoc Health's Depreciation & Amortization (IS) history spans 10 years, with the latest figure at $94.3 million for Q3 2023.

  • For Q3 2023, Depreciation & Amortization (IS) rose 52.08% year-over-year to $94.3 million; the TTM value through Sep 2023 reached $315.3 million, up 35.51%, while the annual FY2022 figure was $256.0 million, 25.36% up from the prior year.
  • Depreciation & Amortization (IS) for Q3 2023 was $94.3 million at Teladoc Health, up from $75.5 million in the prior quarter.
  • Across five years, Depreciation & Amortization (IS) topped out at $94.3 million in Q3 2023 and bottomed at $9.6 million in Q1 2019.
  • The 5-year median for Depreciation & Amortization (IS) is $51.3 million (2021), against an average of $42.5 million.
  • The largest annual shift saw Depreciation & Amortization (IS) fell 1.32% in 2019 before it surged 418.96% in 2021.
  • A 5-year view of Depreciation & Amortization (IS) shows it stood at $9.9 million in 2019, then skyrocketed by 273.82% to $37.0 million in 2020, then skyrocketed by 41.59% to $52.3 million in 2021, then skyrocketed by 44.68% to $75.7 million in 2022, then grew by 24.55% to $94.3 million in 2023.
  • Per Business Quant, the three most recent readings for TDOC's Depreciation & Amortization (IS) are $94.3 million (Q3 2023), $75.5 million (Q2 2023), and $69.8 million (Q1 2023).